New Directions in Drug Approval in Canada
-
Upload
canadian-cancer-survivor-network -
Category
Health & Medicine
-
view
434 -
download
3
Transcript of New Directions in Drug Approval in Canada
![Page 1: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/1.jpg)
![Page 2: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/2.jpg)
2
Webinar Overview• Canada’s regulatory system• Health Canada’s modernization
initiative• The case for reform to support
access to treatments for lethal diseases
• Qs and As / Discussion
![Page 3: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/3.jpg)
3
Review process
Issuance of Notice of Compliance (NOC) and Drug Identification Number (DIN)
Product Label, Brochure & Monograph
Evaluation of Safety, Efficacy, Quality
Review of Submitted Information
New Drug Submission
![Page 4: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/4.jpg)
• Clinical trials
• Establishment licensing, compliance monitoring, verification, investigation, and post-marketing safety
• Imported products, and the testing standards and manufacturing facilities where the products are produced
Health Canada Review
Health Canada also reviews…4
4
![Page 5: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/5.jpg)
5
Health Canada’s Role Today
![Page 6: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/6.jpg)
6
Evolving Lifecycle Approach
![Page 7: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/7.jpg)
7
Regulatory modernization
OBJECTIVES
Access to new
therapiesContinuous monitoring,
assessment and communication of
product information (benefits & harms)
throughout the product lifecycle
Optimal use of therapeutic products to maximize
benefits and minimize risks
![Page 8: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/8.jpg)
• Protecting Canadians from Unsafe Drugs Act, 2014– Recall of unsafe products– Ability to impose tough new penalties on those who sell unsafe products (incl.
imposition of increased fines if violations are intentional)– Ability to compel companies to revise product labels, conduct additional
testing
8
8
Regulatory modernization
– Mandatory adverse event reporting by health care institutions
– Improved transparency regarding Health Canada’s regulatory decisions
– Public posting of all Canadian clinical trial information
– Clarity regarding what constitutes confidential business information and requirement for disclosure when health risks are apparent
![Page 9: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/9.jpg)
9
What’s needed next on regulatory reform?
![Page 10: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/10.jpg)
• The system costs lives and reduces quality of life• A new approach to clinical research is needed• Why we need to speed up the review process• How we can do it• It’s a question of ethics• National strategy for precision medicine• The role of the patient, patient voices and LSTN!
Progress-centered regulatory framework for lethal diseases
10
10
![Page 11: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/11.jpg)
• Special Access Program
• Orphan drugs
• National pharmacare
• Life-cycle reimbursement and patient access (progressive reimbursement)
Other relevant issues and opportunities11
11
![Page 12: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/12.jpg)
12
![Page 13: New Directions in Drug Approval in Canada](https://reader036.fdocuments.in/reader036/viewer/2022062523/58e98b6f1a28aba6498b66eb/html5/thumbnails/13.jpg)
13
Canadian Cancer Survivor Network Contact Info
Canadian Cancer Survivor Network1750 Courtwood Crescent, Suite 210Ottawa, ON K2C 2B5Telephone / Téléphone : 613-898-1871E-mail [email protected] or [email protected] Web site www.survivornet.caBlog: http://jackiemanthornescancerblog.blogspot.com/Twitter: @survivornetcaFacebook: www.facebook.com/CanadianSurvivorNet Pinterest: http://pinterest.com/survivornetwork/